Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfalls.

M Camilleri1

  • 1Enteric Neuroscience Program, Gastroenterology Research Unit, Mayo Clinic, Rochester, MN 55905, USA. camilleri.michael@mayo.edu

Gut
|June 22, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-center Clinical Experience of Diarrhea in Patients Treated With Sorafenib Shows Rare Development of Pancreatic Atrophy.

Gastro hep advances·2024
Same author

Rectal Evacuation Disorders in Patients Presenting With Chronic Functional Diarrhea.

Gastro hep advances·2024
Same author

Comparison of Quality of Life and Psychiatric Symptoms Between Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Those With Constipation-Predominant Irritable Bowel Syndrome.

Gastro hep advances·2023
Same author

Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans.

Neurogastroenterology and motility·2018
Same author

Reproducibility of gastric emptying assessed with scintigraphy in patients with upper GI symptoms.

Neurogastroenterology and motility·2018
Same author

Comparison of pH and motility of the small intestine of healthy subjects and patients with symptomatic constipation using the wireless motility capsule.

International journal of pharmaceutics·2018
Same journal

Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

Gut·2026
Same journal

Dysregulated sphingolipid metabolismdrives pancreatic carcinogenesis through plasma membrane Kras enrichment.

Gut·2026
Same journal

USP20 promotes CD8<sup>+</sup> T cell exhaustion and impairs KRAS<sup>G12D</sup> inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer.

Gut·2026
Same journal

CTCF-rs705704-SUOX axis is important for the association between hypothyroidism and metabolic dysfunction-associated steatotic liver disease.

Gut·2026
Same journal

<i>Helicobacter pylori</i> infection, treatment and colorectal cancer risk by genetic predisposition: evidence from two randomised trials.

Gut·2026
Same journal

Correction: Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis.

Gut·2026
See all related articles

Visceral hypersensitivity is a key factor in functional gastrointestinal disorders like functional dyspepsia and irritable bowel syndrome. This review examines methods for testing this link and discusses current data controversies.

Area of Science:

  • Gastroenterology
  • Neurogastroenterology
  • Visceral Pain Research

Background:

  • Functional gastrointestinal disorders (FGIDs) such as functional dyspepsia and irritable bowel syndrome are prevalent worldwide.
  • Visceral hypersensitivity is a leading hypothesis for the pathophysiology of FGIDs.
  • Understanding the role of visceral sensitivity is crucial for FGID management.

Purpose of the Study:

  • To review the principles and techniques used to test the hypothesis linking visceral sensitivity to FGIDs.
  • To discuss the controversies surrounding the assumptions, methods, and interpretation of data in visceral sensitivity research.
  • To provide a comprehensive overview of the current state of visceral hypersensitivity research in FGIDs.

Main Methods:

  • Literature review of studies investigating visceral sensitivity in FGIDs.

Related Experiment Videos

  • Analysis of methodologies employed in visceral sensitivity testing (e.g., barostat studies, psychophysical testing).
  • Discussion of statistical and interpretive approaches to visceral sensitivity data.

    • Main Results:

    • Visceral hypersensitivity is consistently reported in patients with FGIDs compared to healthy controls.
    • Methodological variations exist in assessing visceral sensitivity, potentially influencing results.
    • Interpretation of data is often debated, particularly regarding causality and clinical relevance.

    Conclusions:

    • Visceral hypersensitivity remains a significant factor in the pathophysiology of functional dyspepsia and irritable bowel syndrome.
    • Further standardization of methods and critical evaluation of data interpretation are needed.
    • Continued research is essential to elucidate the precise role of visceral sensitivity in FGIDs and to develop targeted therapies.